$RPD

Rapid7 (RPD) Stock Trades Down, Here Is Why

Rapid7 (NASDAQ: RPD) shares fell 11.3% in the morning after Morgan Stanley downgraded the stock from Equal Weight to Underweight and kept a $9 price target. The firm cited competitive pressure in vulnerability management from AI-focused rivals and said Rapid7 has lagged in exposure management and real-time remediation. RPD is down 26.5% YTD.

Original reporting
Published Jul 21, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rapid7 (RPD) Stock Trades Down, Here Is Why — source image
Decision brief

The 30-second read

$RPDBearishMed
01

Why it matters

A rating downgrade to Underweight with an unchanged $9 price target is a direct, tradable catalyst that can drive further multiple compression and raise downside expectations.

02

Market read

Traders can use the downgrade and $9 target as a reference point for downside risk and near-term sentiment in vulnerability/exposure management names.

03

What to watch

The piece does not provide Rapid7’s own response, any near-term product milestones, or updated guidance, so the downgrade may be more about relative positioning than imminent financial deterioration.

Relevance 8/10Novelty 6/10Timing: morning session selloff after the downgrade

Background

Rapid7 is a cybersecurity software provider; the article attributes the drop to a Morgan Stanley downgrade tied to exposure management transition progress.

Company-level read

Ticker impact

$RPDBearishMedium confidence
Context

Rapid7 shares fell 11.3% after Morgan Stanley downgraded RPD from Equal Weight to Underweight and kept a $9 target.

Expected impact

Bearish bias for the next several sessions as traders reprice downside risk versus the $9 target.

Evidence & confidence

The article cites a specific rating change and target, plus a concrete thesis: Rapid7 lagging exposure management and real-time remediation versus AI-focused competitors.

Market effects

Highlights vulnerability management as a less defensive cybersecurity segment, potentially pressuring peer sentiment if similar competitive concerns spread.

Primarily US-listed sentiment impact via NASDAQ-listed Rapid7.

Cybersecurity demand narrative remains global, but the catalyst here is company-specific analyst positioning.

Counterpoint

The article frames the move as potentially overdone and notes prior investor interest from major cyber threat advisories, suggesting fundamentals could reassert if competitive execution improves.

Key entities

  • Rapid7

    NASDAQ-listed cybersecurity software provider whose stock fell after an analyst downgrade.

  • Morgan Stanley

    Issued the downgrade from Equal Weight to Underweight and kept a $9 price target.

Related articles

$OFIXMed

These 7 Small Caps Are On Fire In July: Here's Why - ExxonMobil Holdings (NYSE:XOM), Vertex Pharmaceutica

The Russell 2000 stayed near 3,000 with little movement, while seven small-cap stocks gained at least 28% in four sessions. The article cites July surges for Orthofix (OFIX) on CMS reimbursement reversal, REGENXBIO (RGNX) on FDA resubmission alignment and AbbVie milestone, Verastem (VSTM) on short-squeeze setup, ADC Therapeutics (ADCT) rebound, Sable Offshore (SOC) refinancing, Rapid7 (RPD) takeover speculation, and Crinetics (CRNX) surge toward an offer price.

$RPDMedAI 8/10

Rapid7 (RPD) Releases Findings of Q1 Threat Landscape Report

Rapid7 (NASDAQ:RPD) released its Q1 2026 Threat Landscape Report on May 21, citing vulnerability exploitation as 38% of incident response cases. The company said AI is speeding attackers’ ability to identify and exploit unpatched systems. Separately, Barclays lowered its price target and kept an Underweight rating after Rapid7’s Q1 results, citing weaker-than-expected Q2 ARR guidance. Rapid7 projects Q2 ARR of about $820M versus $832M in Q1.

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.